Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Masimo Corp. (NASDAQ: MASI).

Full DD Report for MASI

You must become a subscriber to view this report.


Recent News from (NASDAQ: MASI)

IPO Update: Vapotherm Readies $60 Million IPO Effort
Quick Take Vapotherm ( VAPO ) intends to raise $60 million from the sale of its common stock in an IPO, per an amended registration statement . The company has developed an improved respiratory oxygen flow system. VAPO is growing quickly, but using increasing amounts of cash and showi...
Source: SeekingAlpha
Date: November, 07 2018 12:18
Masimo to Present at Stifel 2018 Healthcare Conference
Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the Stifel 2018 Healthcare Conference at the Palace Hotel in New York on Wednesday, November 14, 2018 at 10:15 a.m. Eastern Time. A live audiocast of the presentation will be available on the Masimo websit...
Source: Business Wire
Date: November, 07 2018 09:00
Masimo: Q3 Confirms Business Quality, Shares Still Pricey
Masimo ( MASI ), one of the most consistent top-line growers in the medical device industry, posted excellent Q3 results buoyed by terrific gross margin expansion and yet another quarter of double-digit product revenue growth. I am increasing the midpoint of my fair value range to $90, though ...
Source: SeekingAlpha
Date: November, 05 2018 05:59
Masimo (MASI) Q3 2018 Results - Earnings Call Transcript
Masimo Corp. (MASI) Q3 2018 Earnings Call October 31, 2018 4:30 pm ET Executives Eli Kammerman - Masimo Corp. Joseph Kiani - Masimo Corp. Micah Young - Masimo Corp. Analysts Rick Wise - Stifel, Nicolaus & Co., Inc. Mike Matson - Needham & Co. LLC William R. Quir...
Source: SeekingAlpha
Date: October, 31 2018 20:25
Masimo Q3 top line up 9%; earnings up 59%; guidance raised
Masimo (NASDAQ: MASI ) Q3 results ($M): Revenue: 210.6 (+8.9%). More news on: Masimo Corporation, Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Source: SeekingAlpha
Date: October, 31 2018 16:18
Masimo beats by $0.02, beats on revenue
Masimo (NASDAQ: MASI ): Q3 Non-GAAP EPS of $0.71 beats by $0.02 ; GAAP EPS of $1.02 beats by $0.31 . More news on: Masimo Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: October, 31 2018 16:09
Masimo Reports Third Quarter 2018 Financial Results
Q3 2018 Highlights Total revenue, including royalty and other revenue, was $210.6 million; Product revenue increased 12.4% to $202.1 million, or 12.8% on a constant currency basis; Shipments of noninvasive technology boards and monitors were 59,100; and GAAP net income per...
Source: Business Wire
Date: October, 31 2018 16:05
Notable earnings after Wednesday's close
ADSW , AIG , ALL , AMGP , AMN , APA , AR , ATH , AWK , AXTI , BLDP , CACI , CDE , CF , CHDN , CLI , CMP , CMPR , CNO , CRY , ENSG , ESRT , ESRX , FARO , FISV , FIT , FORM , FOXF , FRAC , FRT , HBM , HCC , HGV , HPR , JBT , KRG , KW , LHCG , LSI , MAA ...
Source: SeekingAlpha
Date: October, 30 2018 17:35
Masimo Announces FDA Clearance for Masimo RD Sensors with Improved Accuracy Specifications for SET® Pulse Oximetry
Masimo  (NASDAQ: MASI) announced today that RD SET™ sensors with Masimo Measure-through Motion and Low Perfusion™ SET ® pulse oximetry have received FDA clearance with improved SpO 2 accuracy specifications for all patients > 3 kg. RD SET single-patient-use sens...
Source: Business Wire
Date: October, 25 2018 08:00
Your Daily Scoop: Five Prime Progresses, Endocyte's rPFS And Stock Offering, Tracon's Results Published
Stocks in News: FPRX, ECYT Five Prime launches late-stage study of bemarituzumab + chemo in gastric cancer or GEJ Discussion : Five Prime Therapeutics' ( FPRX ) FPA144 (bemarituzumab) plus chemotherapy completed Part 1 of a Phase 1/3 clinical trial evaluating treatment-naive patients ...
Source: SeekingAlpha
Date: September, 12 2018 13:55

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-14119.40121.55121.96119.1949607,866
2017-02-0374.6474.5975.0074.5026,533
2017-02-0274.1474.4974.6073.70421,570
2017-02-0174.0073.9774.8273.62433,066
2017-01-3171.8273.5873.7271.55496,550

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1328,80656,39251.0817Short
2018-12-1261,141160,29038.1440Short
2018-12-1166,010145,89245.2458Short
2018-12-1055,09990,85260.6470Short
2018-12-0747,56774,70163.6765Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on MASI.


About Masimo Corp. (NASDAQ: MASI)

Logo for Masimo Corp. (NASDAQ: MASI)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $4,788,935,470 - 05/17/2018
  • Issue and Outstanding: 49,487,811 - 01/31/2016

 


Recent Filings from (NASDAQ: MASI)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 01 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 01 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: July, 31 2018
An annual report of employee stock purchase savings and similar plans
Filing Type: 11-KFiling Source: edgar
Filing Date: June, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 04 2018
Specialized Disclosure Report
Filing Type: SDFiling Source: edgar
Filing Date: June, 01 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 07 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 02 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 20 2018

 

 


Daily Technical Chart for (NASDAQ: MASI)

Daily Technical Chart for (NASDAQ: MASI)


Stay tuned for daily updates and more on (NASDAQ: MASI)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: MASI)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in MASI is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of MASI and does not buy, sell, or trade any shares of MASI. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/